Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · IEX Real-Time Price · USD
66.98
+3.13 (4.90%)
Apr 23, 2024, 11:26 AM EDT - Market open
Viking Therapeutics Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Viking Therapeutics stock have an average target of 95.4, with a low estimate of 24 and a high estimate of 138. The average target predicts an increase of 42.43% from the current stock price of 66.98.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for VKTX stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 10 | 8 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 12 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $116 → $138 | Buy | Maintains | $116 → $138 | +106.03% | Mar 27, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $116 → $138 | Buy | Maintains | $116 → $138 | +106.03% | Mar 26, 2024 |
| BTIG | BTIG | Strong Buy Maintains $100 → $125 | Strong Buy | Maintains | $100 → $125 | +86.62% | Mar 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $90 | Strong Buy | Reiterates | $90 | +34.37% | Mar 26, 2024 |
| Stifel | Stifel | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +19.44% | Mar 15, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.15
from -0.91
EPS Next Year
-1.55
from -1.15
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 200.7M | 491.4M | 788.7M |
| Avg | n/a | n/a | 30.9M | 189.1M | 492.0M |
| Low | n/a | n/a | n/a | 64.7M | 216.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 1,487.9% | 317.0% |
| Avg | - | - | - | 511.2% | 160.1% |
| Low | - | - | - | 109.0% | 14.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.86 | -1.20 | -0.26 | -2.76 | 0.84 |
| Avg | -1.15 | -1.55 | -1.53 | -2.68 | 0.82 |
| Low | -1.50 | -2.21 | -2.52 | -2.58 | 0.78 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.